esophageal and gastric varices/albumin

Odkaz sa uloží do schránky

Vyberte typ zoradenia

15 výsledky

To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI Development

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

1. Aim- To compare the efficacy of albumin when compared to placebo in the development or progression of AKI in patients with cirrhosis and spontaneous bacterial peritonitis who are at low risk for AKI development (i.e Serum Bilirubin <4 mg/dL and serum creatinine < 1 mg/dl at presentation) -

EUS-guided Obturation of High Risk Gastric Varices Versus Standard Endoscopic Treatment

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

This is a single-centre, pilot randomized trial study that includes 42 patients with gastric varices that will be classified according to the Sarin and Kumar classification into GOV II or IGV I with recently bleeding GV & high-risk GV (defined by Baveno VI consensus for primary

Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The incidence of hepatocellular carcinoma (HCC) is increasing over time among the HIV-infected population, and is an increasingly important cause of morbidity and mortality in HIV-infected individuals. Despite effective treatment for HBV and HCV infections, HCC is still reported in treated

Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Globally, the mortality after any infection in cirrhosis patients is very high. The cumulative mortality in patients with infections was 43.5% (11,987 patients) where as the mortality rate without infection was 13.6% (2317 patients). Over the years, variceal bleeding causing death in cirrhosis has

Non-invasive Methods to Predict PHG in Cirrhosis

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Cirrhosis is the end-stage of every chronic liver disease. Histologically, cirrhosis is characterized by regenerative nodules surrounded by fibrous bands, which can be divided into compensated phase and decompensated one. Compensated phase is referred to as asymptomatic stages, also known as

Long Term Follow-up of Hepatitis C Cured Patients

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

HYPOTHESIS: - The prognosis of cACLD patients who achieve SVR will improve during follow-up and this will be reflected in an improvement in liver and spleen stiffness and reduction of liver-related events. However, on an individual basis, because of many confounding factors, predictability is

Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

The following data will be collected: Demographics information: age, gender, race, country of birth (COB). Data on liver and virological characteristics: Hepatitis C virus(HCV) genotype, fibrosis stage (F0-4), technology of fibrosis assessment (fibroscan, fibrotest, elastography, biopsy), ,

Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

This is an open-label single-dose study. Approximately 40 total subjects will be enrolled. In each of the 3 hepatic impairment groups (mild hepatic dysfunction [Child-Pugh score of 5 - 6], moderate hepatic dysfunction [Child-Pugh score of 7 - 9], severe hepatic dysfunction [Child Pugh score of 10 -

Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Aim: To determine the effectiveness of oral diclophenac sodium on the quality of colonoscopy and pain control during diagnostic colonoscopy in hospitalized patients. Hypothesis: Null hypothesis: there is no statistically significant difference between diclophenac sodium and placebo on parameters of

Efficacy of Granulocyte Colony-stimulating Factor and Erythropoetin for Patients With Acute-on-chronic Liver Failure

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

50 patients of ACLF will be enrolled and randomized into G-CSF+EPO or Placebo arms Baseline investigations: - Hematology - CBC, Prothrombin time and INR - Peripheral smear, Retics - Biochemistry - Liver function testing, AFP - Kidney function test - Etiology of acute event: - Infectious etiology:

B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Diagnostic criteria for the cause of ascites - two independent cardiologists and two hepatologists will interview and examine the enrolled patients and review the clinical records, laboratory and imaging findings to adjudicate the correct final cause of the ascites. They will have access to all

A Prospective Evaluation of Computerized Tomographic(CT) Scanning as a Screening Modality for Esophageal Varices

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Study Group -We screened a population of 581 consecutive patients with cirrhosis who were scheduled to undergo upper gastrointestinal endoscopy. Exclusion criteria included inability to provide consent, patients who had previously undergone liver transplantation, previous portosystemic shunt

Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered Stents

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt With 8- or 10-mm Covered Stents in Cirrhotic Patients: A Randomized Controlled Study Introduction In the treatment of esophageal varices rebleeding1 and ascites/hydrothorax refractory to the diuretic therapy2 by transjugular

Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma

Články môžu prekladať iba registrovaní používatelia

Prihlásiť Registrácia

1. TREATMENT PLAN 1.1 Eligible patients are randomized to receive adjuvant IFN-α for 53 wks or 1.2 Administration of IFN-α 1.21 IFN-α will be started after randomization. 1.22 IFN-α will be administered by subcutaneous injection at the bed time. 1.23 Escalation of IFN-α dosage. 1.231 During the

Pripojte sa k našej
facebookovej stránke

Herbal & Natural Medicine

Najkompletnejšia databáza liečivých bylín podporovaná vedou

Pracuje v 55 jazykoch
Bylinné lieky podporené vedou
Rozpoznávanie bylín podľa obrázka
Interaktívna GPS mapa - označte byliny na mieste (už čoskoro)
Prečítajte si vedecké publikácie týkajúce sa vášho hľadania
Vyhľadajte liečivé byliny podľa ich účinkov
Usporiadajte svoje záujmy a držte krok s novinkami, klinickými skúškami a patentmi

Zadajte príznak alebo chorobu a prečítajte si o bylinách, ktoré by vám mohli pomôcť, napíšte bylinu a pozrite sa na choroby a príznaky, proti ktorým sa používa.
* Všetky informácie sú založené na publikovanom vedeckom výskume